** Shares of Hims & Hers Health HIMS.N down 0.4% to $51.19 before the bell as telehealth firm's capital raise boosted by ~90%
** San Francisco, California-based co late Thurs announced $870 mln 0% 5-yr convertible bond offering, upsized from $450 mln
** Initial conversion price of $70.67 represents 37.5% premium to stock's last close
** Co plans to use net proceeds for general purposes, including accelerating global expansion through organic growth and potential acquisitions
** It intends to use ~$42 mln of net proceeds to pay for capped calls, derivative transactions employed to offset share dilution
** Before the bell Thurs, co appointed Mo Elshenawy, former chief technology officer of General Motors' self-driving vehicle unit Cruise, as its new CTO
** Co has $11.5 bln market cap, per LSEG data
** On Apr 29, HIMS jumped 23% to close at $35.04 after Denmark's Novo Nordisk NOVOb.CO said it would sell its popular weight-loss drug Wegovy through telehealth firms
** Through Thurs, HIMS has nearly doubled over the past month. Stock hit record intraday high of $72.98 on Feb 19
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.